PPARG and hyperlipidemia: The discovery that the lipid-activated PPARγ nuclear receptor is essential for adipocyte development has contributed to our understanding of adipose tissue biology and the role of PPARγ regulation in obesity-related diseases such as hyperlipidemia, insulin resistance, type 2 diabetes mellitus, obesity, and cardiovascular diseases [1].